Thus, at least some fear- and depression-related behaviors related to rapid antidepressant or anxiolytic effects can be modulated by NR2B- and PKA-mediated mechanisms independently of changes in Bdnf levels. The gene discussed is GRIN2B; the disease is depressive disorder.